2023
1358-P: Disparities in Acute and Chronic Complications of Diabetes in Rural U.S.
STEIGER K, HERRIN J, SWARNA K, MCCOY R. 1358-P: Disparities in Acute and Chronic Complications of Diabetes in Rural U.S. Diabetes 2023, 72 DOI: 10.2337/db23-1358-p.Peer-Reviewed Original ResearchChronic diabetes complicationsDiabetes complicationsKidney diseaseMyocardial infarctionGreater incidenceEnd-stage kidney diseaseIncidence of strokeRate of complicationsLower extremity ulcersDiabetes-related complicationsHealth care utilizationOptumLabs Data WarehouseMedicare Advantage beneficiariesChronic complicationsCharcot jointExtremity ulcersHeart failureSevere hypoglycemiaCare utilizationSevere hyperglycemiaAtrial fibrillationLower incidenceComplicationsHigh incidenceDiabetesEvaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes
Jiang D, Herrin J, Van Houten H, McCoy R. Evaluation of High-Deductible Health Plans and Acute Glycemic Complications Among Adults With Diabetes. JAMA Network Open 2023, 6: e2250602. PMID: 36662531, PMCID: PMC9860518, DOI: 10.1001/jamanetworkopen.2022.50602.Peer-Reviewed Original ResearchConceptsHigh-deductible health plansSevere hypoglycemiaED visitsHealth plansCohort studyHDHP enrollmentPotential treatment selection biasAcute diabetes complicationsGlucose-lowering medicationsRetrospective cohort studyOptimal diabetes careAdministrative claims dataTreatment selection biasMixed effects logistic regression modelsLogistic regression modelsGlycemic complicationsGlycemic controlPatient ageDiabetes complicationsDiabetes careHospital visitsStudy populationInverse propensity scoreMAIN OUTCOMEClaims data
2021
Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study.
Mauras N, Buckingham B, White NH, Tsalikian E, Weinzimer SA, Jo B, Cato A, Fox LA, Aye T, Arbelaez AM, Hershey T, Tansey M, Tamborlane W, Foland-Ross LC, Shen H, Englert K, Mazaika P, Marzelli M, Reiss AL. Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study. Diabetes Care 2021, 44: 983-992. PMID: 33568403, PMCID: PMC7985430, DOI: 10.2337/dc20-2125.Peer-Reviewed Original ResearchConceptsType 1 diabetesBrain volumeControl subjectsTotal brain volume differencesEarly-onset type 1 diabetesAge-matched control subjectsIntelligence quotientCognitive scoresWhite matter volumeBrain volume differencesContinuous glucose monitoringDiabetes groupFull-scale intelligence quotientDiabetes complicationsDiabetes controlTotal brainVerbal intelligence quotientDiabetesMatter volumeSensor glucoseCognitive testingGlucose monitoringMixed-effects modelsBrainGroup differences
2020
Incident diabetes complications among women with type 1 diabetes based on parity
Polsky S, Foster NC, DuBose SN, Agarwal S, Lyons S, Peters AL, Uwaifo GI, DiMeglio LA, Sherr JL, Levy CJ. Incident diabetes complications among women with type 1 diabetes based on parity. The Journal Of Maternal-Fetal & Neonatal Medicine 2020, 35: 4629-4634. PMID: 33280471, DOI: 10.1080/14767058.2020.1858278.Peer-Reviewed Original ResearchConceptsType 1 diabetesParous womenNulliparous womenDiabetes complicationsRisk factorsHigher Body Mass IndexAdverse lipid profileTriglyceride/HDLOverweight/obesityBody mass indexAdvanced nephropathyMass indexT1D ExchangeFirst pregnancyPregnant womenChildbirth QuestionnaireLipid profileCardiovascular diseaseComplicationsWomenHypertensionYear 5Further studiesSignificant differencesDiabetes
2018
Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries
Klingensmith GJ, Lanzinger S, Tamborlane WV, Hofer SE, Cheng P, de Beaufort C, Gal RL, Reinehr T, Kollman C, Holl RW. Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries. Pediatric Diabetes 2018, 19: 1156-1163. PMID: 29923263, DOI: 10.1111/pedi.12712.Peer-Reviewed Original ResearchConceptsDiabetes durationClinical characteristicsBody mass index SDSAdolescent type 2Onset of T2DPediatric Diabetes ConsortiumShorter diabetes durationMost recent visitType 2 diabetesYears of ageProspective registryTreatment of youthAdverse eventsDiabetes complicationsHigher HbA1cOffice visitsHigher hemoglobinUnited States databaseVs 3.2Diabetes testingType 2RegistryLaboratory dataTreatment differencesFurther studiesElevated Thrombospondin‐2 Contributes to Delayed Wound Healing in Diabetes
Kunkemoeller B, Kyriakides T. Elevated Thrombospondin‐2 Contributes to Delayed Wound Healing in Diabetes. The FASEB Journal 2018, 32: 414.3-414.3. DOI: 10.1096/fasebj.2018.32.1_supplement.414.3.Peer-Reviewed Original ResearchKO mice exhibitThrombospondin-2TSP2 expressionDiabetes patientsImpaired healingMouse modelWound healingMice exhibitDb/db miceWild-type miceKO mouse modelUnderlying pathological mechanismsImpaired wound healingDelayed Wound HealingFull-text articlesMajor complicationsDiabetes complicationsDb miceKO miceTreatment strategiesTissue injuryDiabetesPathological mechanismsDiabetic woundsChronic wounds
2017
Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events
McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events. Journal Of General Internal Medicine 2017, 32: 1097-1105. PMID: 28685482, PMCID: PMC5602759, DOI: 10.1007/s11606-017-4095-x.Peer-Reviewed Original ResearchConceptsDiabetes Complications Severity IndexSevere dysglycemiaIndex hospitalizationMedicare Advantage beneficiariesRisk factorsBetter care transitionsComplications Severity IndexPost-discharge managementIndependent risk factorYounger patient ageOptumLabs Data WarehouseStrong risk factorYears of ageBackgroundHospital readmissionsDesignRetrospective analysisCause readmissionUnplanned readmissionPatient agePrior hospitalizationReadmission ratesYounger patientsHeart failureHospital readmissionSevere hypoglycemiaDiabetes complicationsSubstance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination
Walter KN, Wagner JA, Cengiz E, Tamborlane WV, Petry NM. Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination. Current Diabetes Reports 2017, 17: 2. PMID: 28101793, DOI: 10.1007/s11892-017-0832-0.Peer-Reviewed Original ResearchConceptsType 2 diabetesLong-term diabetes complicationsDiabetes complicationsSubstance useUse disordersPsychosocial smoking cessation interventionsPopulation-based epidemiological studyPopulation-based studySmoking cessation interventionLarge population-based epidemiological studiesSelf-management behaviorsSubstance use disordersAlcohol use disorderIllicit drug useRecent FindingsRatesSmoking rangeDiabetes onsetCessation interventionsDiabetes outcomesPharmacological interventionsEpidemiological dataEpidemiological studiesGlucose homeostasisDiabetesSUD interventions
2016
A Contemporary Evaluation of the Cause of Death and Long‐Term Quality of Life After Total Pancreatectomy
Wu W, Dodson R, Makary MA, Weiss MJ, Hirose K, Cameron JL, Ahuja N, Pawlik TM, Wolfgang CL, He J. A Contemporary Evaluation of the Cause of Death and Long‐Term Quality of Life After Total Pancreatectomy. World Journal Of Surgery 2016, 40: 2513-2518. PMID: 27177647, DOI: 10.1007/s00268-016-3552-8.Peer-Reviewed Original ResearchConceptsCause of deathTotal pancreatectomyInsulin-dependent diabetesDiabetes-dependent QoLSF-36 surveyShort Form-36Majority of deathsLong-term qualityTotal hospitalizationsForm-36Preoperative stateDiabetes complicationsPreoperative assessmentWorse QOLDiabetic complicationsQOL surveyDiffuse diseasePatientsPancreatic enzymesQoLEuropean OrganizationHealth changesLife implicationsDeathPancreatectomy
2015
Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications
Marzagalli R, Scuderi S, Drago F, Waschek J, Castorina A. Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications. International Journal Of Endocrinology 2015, 2015: 160928. PMID: 26074958, PMCID: PMC4446501, DOI: 10.1155/2015/160928.Peer-Reviewed Original ResearchMajor complicationsNeuropeptide pituitary adenylate cyclaseMajor diabetes complicationsMajor diabetic complicationsNew potential therapeutic targetsCause of morbidityCause of diabetesPituitary adenylate cyclasePotential therapeutic targetRole of PACAPPancreatic islet dysfunctionLongstanding diabetesDiabetes complicationsRange of pathologiesDiabetic complicationsHyperglycemic stateMillions of individualsIslet dysfunctionPeptide-based therapiesComplicationsTherapeutic targetDiabetesAdenylate cyclaseSecondary damageLife expectancy
2010
The DIALBEST Type 2 diabetes peer counseling intervention: Process evaluation
Cruz R, Segura S, Damio G, Perez‐Escamilla R. The DIALBEST Type 2 diabetes peer counseling intervention: Process evaluation. The FASEB Journal 2010, 24: 741.8-741.8. DOI: 10.1096/fasebj.24.1_supplement.741.8.Peer-Reviewed Original ResearchDiabetes complicationsPeer counseling interventionPhysical activity interventionsTopic of nutritionLow-fat foodsActivity interventionsMedication managementLifestyle changesEducational sessionsHealth disparitiesEliminating Health DisparitiesAverage durationMajority of sessionsFat foodsFast foodPC contactFood labelsProcess evaluationCounseling interventionComplicationsDiabetesPatientsInterventionGrant funding sourcesSessionsThe Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T. The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes. Diabetes Care 2010, 33: 1269-1274. PMID: 20332354, PMCID: PMC2875436, DOI: 10.2337/dc09-2042.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioContinuous glucose monitoringType 1 diabetic patientsImproved glucose controlCost-effectiveness analysisGlucose controlDiabetic patientsGlucose monitoringBenefits of CGMType 1 diabetes complicationsTest strip useType 1 diabetesCost-effectiveness ratioStandard glucose monitoringMicrovascular complicationsDiabetes complicationsTrial populationSocietal cost-effectiveness analysisGlycemic benefitsLong-term effectsMAIN OUTCOMELife benefitsQALY thresholdStrip useTrial data
2007
The transition to young adulthood in youth with type 1 diabetes on intensive treatment
Insabella G, Grey M, Knafl G, Tamborlane W. The transition to young adulthood in youth with type 1 diabetes on intensive treatment. Pediatric Diabetes 2007, 8: 228-234. PMID: 17659065, DOI: 10.1111/j.1399-5448.2007.00266.x.Peer-Reviewed Original ResearchConceptsQuality of lifeDepressive symptomsYoung adulthoodIntensive treatmentPsychosocial outcomesDisease-related worriesPediatric diabetes clinicType 1 diabetesChart reviewComplications TrialDiabetes clinicIntensive therapyDiabetes complicationsDiabetes controlTreatment groupsSuch symptomsMetabolic controlIntervention studiesSymptomsDiabetesYoung adultsEarly adulthoodLonger durationHigh levelsAdulthood
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply